AF
TWST icon

Avanza Fonder’s Twist Bioscience TWST Stock Holding History

Avanza Fonder’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,904
Closed -$837K – 486
2025
Q1 		$837K Sell
21,904
-887
-4% -$40K 0.03% 365
2024
Q4 		$1.06M Buy
+22,791
New +$1.03M 0.03% 332

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Avanza Fonder's TWST Position: Q2 2025 in Review

Avanza Fonder sold out of Twist Bioscience (TWST) in Q2 2025, closing a stake of 21,904 shares — an estimated $837K sold.

Avanza Fonder first reported a position in TWST in Q4 2024 and held it in 2 quarters. The position peaked at $1.06M in Q4 2024. 243 funds tracked by Wall St. Rank hold TWST as of Q2 2025.

  • Avanza Fonder reported no remaining Twist Bioscience position as of Q2 2025 after selling out during the quarter.
  • Avanza Fonder sold 21,904 Twist Bioscience shares in Q2 2025, an estimated $837K.
  • Avanza Fonder first reported a position in Twist Bioscience in Q4 2024 and held it in 2 quarters.
  • Avanza Fonder's Twist Bioscience position peaked at $1.06M in Q4 2024.
  • 243 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2025.

Based on Avanza Fonder's 13F filing for Q2 2025, filed 14 Jul 2025.